Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Pharmacol ; 76(6): 1279-89, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19726551

RESUMO

Expression of KCNQ2/3 (Kv7.2 and -7.3) heteromers underlies the neuronal M current, a current that is suppressed by activation of a variety of receptors that couple to the hydrolysis of phosphatidylinositol 4,5-bisphosphate. Expression of Kv7.2/7.3 channels in human embryonic kidney (HEK) 293 cells produced a noninactivating potassium current characteristic of M current. Muscarinic receptors endogenous to HEK293 cells were identified as being M3 by pharmacology and Western blotting, producing a rise of intracellular calcium ([Ca2+](i)) upon activation. Activation of these endogenous muscarinic receptors however, failed to suppress expressed Kv7.2/7.3 current. Current suppression was reconstituted by coexpression of HA-tagged muscarinic m1 or m3 receptors. Examination of membrane fractions showed that both expressed receptors and Kv7.2 and -7.3 channel subunits resided within lipid rafts. Disruption of lipid rafts by pretreatment of cells expressing either m1 or m3 muscarinic receptors with methyl-beta-cyclodextrin produced a loss of localization of proteins within lipid raft membrane fractions. This pretreatment also abolished both the increase of [Ca2+](i) and suppression of expressed Kv7.2/7.3 current evoked by activation of expressed m1 or m3 muscarinic receptors. A similar loss of muscarinic receptor-mediated suppression of M current native to rat dorsal root ganglion neurons was observed after incubating dissociated cells with methyl-beta-cyclodextrin. These data suggested that lipid rafts colocalized both muscarinic receptors and channel subunits to enable receptor-mediated suppression of channel activity, a spatial colocalization that enables specificity of coupling between receptor and ion channel.


Assuntos
Microdomínios da Membrana/efeitos dos fármacos , Canais de Potássio/efeitos dos fármacos , Animais , Western Blotting , Cálcio/metabolismo , Carbacol/farmacologia , Linhagem Celular , Colinérgicos/farmacologia , Gânglios Espinais/citologia , Humanos , Canal de Potássio KCNQ2/efeitos dos fármacos , Canal de Potássio KCNQ2/metabolismo , Canal de Potássio KCNQ3/efeitos dos fármacos , Canal de Potássio KCNQ3/metabolismo , Microdomínios da Membrana/metabolismo , Potenciais da Membrana/efeitos dos fármacos , Camundongos , Muscarina/farmacologia , Oxotremorina/farmacologia , Fosfatidilinositol 4,5-Difosfato/farmacologia , Bloqueadores dos Canais de Potássio/farmacologia , Receptor Muscarínico M1/efeitos dos fármacos , Receptor Muscarínico M3/efeitos dos fármacos , Receptores Muscarínicos/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...